Neuromodulation and Mindfulness Patients With AUD

Launched by CHARITE UNIVERSITY, BERLIN, GERMANY · Mar 6, 2024

Keywords

ClinConnect Summary

This clinical trial is exploring a new approach to help people who are trying to recover from alcohol dependence. The researchers want to see if combining a technique called transcutaneous vagus nerve stimulation (tVNS) with mindfulness meditation can improve the effectiveness of a program designed to prevent relapse after detoxification. They will look at how this combination affects drinking habits, cravings for alcohol, and the overall seriousness of alcohol dependence over a period of three months after treatment.

To participate in this study, individuals need to be between the ages of 18 and 65 and have been alcohol-dependent but sober for at least three days and no more than 12 months. However, people with certain conditions, such as other substance use disorders, serious neurological disorders, or severe mental health issues, will not be eligible to join. Participants can expect to engage in mindfulness meditation exercises while receiving specific brain stimulation aimed at enhancing their ability to manage cravings and maintain sobriety. This trial is currently recruiting participants, and it's an exciting opportunity for those looking for new ways to support their recovery journey.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Alcohol Dependence (ICD-10)
• • abstinence between 3 days and 12 months
• Exclusion Criteria:
• • current (last 12 months) substance use disorder/dependence
• • neurological disorders (e.g. epilepsy, neuropathy, multiple sclerosis)
• • current severe major depressive disorder, manic episode or schizophreniform disorder
• • intake of anticonvulsive or high-potency antipsychotic medication